EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor β type II receptor gene

Young Hyuck Im, Heung Tae Kim, Cecile Lee, Danielle Poulin, Scott Welford, Poul H.B. Sorensen, Christopher T. Denny, Seong Jin Kim

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Ewing sarcoma-specific chromosomal translocations fuse the EWS gene to a subset of ets transcription factor family members, most commonly the FLI1 gene and less frequently ERG, ETV1, EIA-F, or FEV. These fusion proteins are thought to act as aberrant transcription factors that bind DNA through their ets DNA binding domain. Recently, we have shown (K-B. Hahm et al., Nat. Genet., 23: 222-227, 1999) that the transforming growth factor β (TGF-β) type II receptor (TGF-β RII), a putative tumor suppressor gene, is a target of the EWS-FLI1 fusion protein. Here, we also examined effects of EWS-ETV1 and EWS-ERG on expression of the TGF-β RII gene. We show that relative to the control, NIH-3T3 cell lines stably transfected with the EWS-FLI1, EWS- ERG, or EWS-ETV1 gene fusion express reduced levels of TGF-β RII mRNA and protein, and that these cell lines have reduced TGF-β sensitivity. Cotransfection of these fusion genes and the TGF-β RII promoter suppresses TGF-β RII promoter activity and also FLI1-, ERG-, or ETV1-induced promoter activity. These results indicate that transcriptional repression of TGF-β RII is an important target of the EWS-FLI1, EWS-ERG, or EWS-ETV1 oncogene, and that EWS-ets fusion proteins may function as dominant negative forms of ets transcription factors.

Original languageEnglish (US)
Pages (from-to)1536-1540
Number of pages5
JournalCancer Research
Volume60
Issue number6
StatePublished - Mar 15 2000
Externally publishedYes

Fingerprint

Ewing's Sarcoma
Growth Factor Receptors
Oncogene Proteins
Transforming Growth Factors
Genes
Proto-Oncogene Proteins c-ets
Gene Fusion
Viverridae
Cell Line
NIH 3T3 Cells
Genetic Translocation
Proteins
EWS-FLI fusion protein
DNA
Tumor Suppressor Genes
Oncogenes
Transcription Factors
Messenger RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor β type II receptor gene. / Im, Young Hyuck; Kim, Heung Tae; Lee, Cecile; Poulin, Danielle; Welford, Scott; Sorensen, Poul H.B.; Denny, Christopher T.; Kim, Seong Jin.

In: Cancer Research, Vol. 60, No. 6, 15.03.2000, p. 1536-1540.

Research output: Contribution to journalArticle

Im, Young Hyuck ; Kim, Heung Tae ; Lee, Cecile ; Poulin, Danielle ; Welford, Scott ; Sorensen, Poul H.B. ; Denny, Christopher T. ; Kim, Seong Jin. / EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor β type II receptor gene. In: Cancer Research. 2000 ; Vol. 60, No. 6. pp. 1536-1540.
@article{ff8334421caa4cdeb8634d91cba850e6,
title = "EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor β type II receptor gene",
abstract = "Ewing sarcoma-specific chromosomal translocations fuse the EWS gene to a subset of ets transcription factor family members, most commonly the FLI1 gene and less frequently ERG, ETV1, EIA-F, or FEV. These fusion proteins are thought to act as aberrant transcription factors that bind DNA through their ets DNA binding domain. Recently, we have shown (K-B. Hahm et al., Nat. Genet., 23: 222-227, 1999) that the transforming growth factor β (TGF-β) type II receptor (TGF-β RII), a putative tumor suppressor gene, is a target of the EWS-FLI1 fusion protein. Here, we also examined effects of EWS-ETV1 and EWS-ERG on expression of the TGF-β RII gene. We show that relative to the control, NIH-3T3 cell lines stably transfected with the EWS-FLI1, EWS- ERG, or EWS-ETV1 gene fusion express reduced levels of TGF-β RII mRNA and protein, and that these cell lines have reduced TGF-β sensitivity. Cotransfection of these fusion genes and the TGF-β RII promoter suppresses TGF-β RII promoter activity and also FLI1-, ERG-, or ETV1-induced promoter activity. These results indicate that transcriptional repression of TGF-β RII is an important target of the EWS-FLI1, EWS-ERG, or EWS-ETV1 oncogene, and that EWS-ets fusion proteins may function as dominant negative forms of ets transcription factors.",
author = "Im, {Young Hyuck} and Kim, {Heung Tae} and Cecile Lee and Danielle Poulin and Scott Welford and Sorensen, {Poul H.B.} and Denny, {Christopher T.} and Kim, {Seong Jin}",
year = "2000",
month = "3",
day = "15",
language = "English (US)",
volume = "60",
pages = "1536--1540",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor β type II receptor gene

AU - Im, Young Hyuck

AU - Kim, Heung Tae

AU - Lee, Cecile

AU - Poulin, Danielle

AU - Welford, Scott

AU - Sorensen, Poul H.B.

AU - Denny, Christopher T.

AU - Kim, Seong Jin

PY - 2000/3/15

Y1 - 2000/3/15

N2 - Ewing sarcoma-specific chromosomal translocations fuse the EWS gene to a subset of ets transcription factor family members, most commonly the FLI1 gene and less frequently ERG, ETV1, EIA-F, or FEV. These fusion proteins are thought to act as aberrant transcription factors that bind DNA through their ets DNA binding domain. Recently, we have shown (K-B. Hahm et al., Nat. Genet., 23: 222-227, 1999) that the transforming growth factor β (TGF-β) type II receptor (TGF-β RII), a putative tumor suppressor gene, is a target of the EWS-FLI1 fusion protein. Here, we also examined effects of EWS-ETV1 and EWS-ERG on expression of the TGF-β RII gene. We show that relative to the control, NIH-3T3 cell lines stably transfected with the EWS-FLI1, EWS- ERG, or EWS-ETV1 gene fusion express reduced levels of TGF-β RII mRNA and protein, and that these cell lines have reduced TGF-β sensitivity. Cotransfection of these fusion genes and the TGF-β RII promoter suppresses TGF-β RII promoter activity and also FLI1-, ERG-, or ETV1-induced promoter activity. These results indicate that transcriptional repression of TGF-β RII is an important target of the EWS-FLI1, EWS-ERG, or EWS-ETV1 oncogene, and that EWS-ets fusion proteins may function as dominant negative forms of ets transcription factors.

AB - Ewing sarcoma-specific chromosomal translocations fuse the EWS gene to a subset of ets transcription factor family members, most commonly the FLI1 gene and less frequently ERG, ETV1, EIA-F, or FEV. These fusion proteins are thought to act as aberrant transcription factors that bind DNA through their ets DNA binding domain. Recently, we have shown (K-B. Hahm et al., Nat. Genet., 23: 222-227, 1999) that the transforming growth factor β (TGF-β) type II receptor (TGF-β RII), a putative tumor suppressor gene, is a target of the EWS-FLI1 fusion protein. Here, we also examined effects of EWS-ETV1 and EWS-ERG on expression of the TGF-β RII gene. We show that relative to the control, NIH-3T3 cell lines stably transfected with the EWS-FLI1, EWS- ERG, or EWS-ETV1 gene fusion express reduced levels of TGF-β RII mRNA and protein, and that these cell lines have reduced TGF-β sensitivity. Cotransfection of these fusion genes and the TGF-β RII promoter suppresses TGF-β RII promoter activity and also FLI1-, ERG-, or ETV1-induced promoter activity. These results indicate that transcriptional repression of TGF-β RII is an important target of the EWS-FLI1, EWS-ERG, or EWS-ETV1 oncogene, and that EWS-ets fusion proteins may function as dominant negative forms of ets transcription factors.

UR - http://www.scopus.com/inward/record.url?scp=0342424350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342424350&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 1536

EP - 1540

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 6

ER -